2010
DOI: 10.1016/j.bmcl.2010.04.094
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of 6-chloro-2-trifluoromethyl-7-aryl-7H-imidazo[1,2-a]imidazol-3-ylmethylamines, a novel class of corticotropin-releasing factor receptor type 1 (CRF1R) antagonists

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2010
2010
2019
2019

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 18 publications
0
3
0
Order By: Relevance
“…Other conditions (base, solvents) were tested in order to change the selectivity of the reaction, which turned out to be unsuccessful 11. Without further separation, 5a and 5b were engaged in an intramolecular silver salt assisted cyclisation performed in tetramethylene sulfone at 150 °C during 12 h2c according to the conditions of Zuev and Dubowchik's group. Unfortunately, the totality of the starting material was recovered, leading us to develop a different and innovative strategy.…”
Section: Resultsmentioning
confidence: 99%
“…Other conditions (base, solvents) were tested in order to change the selectivity of the reaction, which turned out to be unsuccessful 11. Without further separation, 5a and 5b were engaged in an intramolecular silver salt assisted cyclisation performed in tetramethylene sulfone at 150 °C during 12 h2c according to the conditions of Zuev and Dubowchik's group. Unfortunately, the totality of the starting material was recovered, leading us to develop a different and innovative strategy.…”
Section: Resultsmentioning
confidence: 99%
“…The imidazo-imidazole scaffolds hold a special place in this category, since they are found in compounds showing a wide range of pharmaceutical activities. In particular, they have been described as antifungal (Lila et al, 2003), antithrombotic (Imaeda et al, 2008; Fujimoto et al, 2009), anxiolytic and anti-depressive agents (Han et al, 2005; Tellew and Luo, 2008; Zuev et al, 2010). In addition, they have been reported as androgen receptor agonists and antagonists that are useful in the treatment of a variety of disorders (Zhang et al, 2006).…”
Section: Introductionmentioning
confidence: 99%
“…Recently, our group made significant efforts to discover a new synthetic route and study the chemical reactivity of [5–5]­fused ring systems . In particular, the imidazo­[1,2- a ]­imidazole unit has been studied as a CRF 1 R antagonist involved in diseases such as depression and anxiety …”
Section: Introductionmentioning
confidence: 99%